What Happened? Shares of scientific instruments company Waters Corporation (NYSE:WAT) fell 12.8% in the morning session after ...

A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...

Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.

Waters Corp.'s $17.5B merger with BD Biosciences aims to double revenue but raises risks. Read here for an investment ...

Waters Corporation is merging with BD’s Biosciences and Diagnostic Solutions business in a $17.5 billion deal to expand its capabilities in life sciences and diagnostics.

Kirkland & Ellis advises Waters on $17.5B merger with Becton Dickinson, creating a diagnostics and life sciences leader.

Shares of Waters Corp. WAT advanced 2.06% to $287.46 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.06% to 6,309.62 and ...

Waters Corp. closed 32.12% below its 52-week high of $423.56, which the company achieved on January 30th.

Waters Corporation beat analysts’ revenue expectations by 3.9% last quarter, reporting revenues of $740.3 million, up 4% year on year. It was a very strong quarter for the company, ...

Waters Corp. boasts about 7,600 employees worldwide, with products available in more than 100 countries. For 2024, the company reported profits of $637.8 million ($10.71 per share) ...